Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Expert Review of Pharmacoeconomics & Outcomes Research|July 25, 2017
Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT)Florian Wagenlehner, Björn Wullt, Stefania Ballarini, et al.
Cellular Microbiology|March 16, 2007
Do type 1 fimbriae promote inflammation in the human urinary tract?Göran Bergsten, Björn Wullt, Mark A Schembri, et al.
Microbiology Spectrum|June 24, 2016
Susceptibility to Urinary Tract Infection: Benefits and Hazards of the Antibacterial Host ResponseInes Ambite, Karoly Nagy, Gabriela Godaly, et al.
Pathogens (Basel, Switzerland)|July 16, 2016
Bacterial Suppression of RNA Polymerase II-Dependent Host Gene ExpressionInes Ambite, Nataliya Lutay, Christoph Stork, et al.
International Journal of Cancer|May 22, 2007
Bladder cancers respond to intravesical instillation of HAMLET (human alpha-lactalbumin made lethal to tumor cells)Ann-Kristin Mossberg, Björn Wullt, Lotta Gustafsson, et al.
Plos One|December 6, 2011
Genetic control of the variable innate immune response to asymptomatic bacteriuriaJenny Grönberg-Hernández, Jenny Grönberg Hernández, Fredrik Sundén, et al.
European Urology Open Science|September 1, 2021
Immunomodulation-A Molecular Solution to Treating Patients with Severe Bladder Pain Syndrome?Björn Wullt, Daniel S C Butler, Ines Ambite, et al.
European Urology|March 15, 2006
Mucosal host responses to bacteriuria in colonic and ileal neobladdersBjörn Wullt, Göran Bergsten, Jens Carstensen, et al.
Nature Reviews. Urology|June 22, 2022
Immunomodulation therapy offers new molecular strategies to treat UTIDaniel Butler, Ines Ambite, Murphy Lam Yim Wan, et al.
Advances in Experimental Medicine and Biology|January 11, 2008
Apoptosis and tumor cell death in response to HAMLET (human alpha-lactalbumin made lethal to tumor cells)Oskar Hallgren, Sonja Aits, Patrick Brest, et al.
Pageof 5